Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study
BMC Gastroenterology · 2024
DOI: 10.1186/s12876-024-03477-4 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Mohammad Rezazadeh und 11 weiteren Autor:innen. Beteiligte Einrichtung: Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Diabetes Mellitus, Type 2, Sulfonylurea Compounds, Hypoglycemic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
BACKGROUND AND AIMS: Colorectal cancer (CRC) is a significant global health concern, with studies estimating a rise in new cases to 2.5 million by 2035. Type 2 diabetes (T2D) is also a growing issue, with an estimated 642 million adults affected by 2040. However, the relationship between T2D, its medications, and CRC remains unclear. MATERIALS AND METHODS: This case-control study includes 810 controls without CRC and 684 cases with CRC admitted to Rasoul-Akram and Firouzgar Hospitals from September 2019 to 2023. Adjusted and unadjusted odds ratios (OR) were calculated to investigate the effect of T2D and sulfonylurea consumption on the chance of CRC development, using univariate and multivariate logistic regression analyses. The relationship between T2D and the clinicopathological features of the tumor was investigated. RESULTS: The results show that the effect of T2D on CRC is significant based on unadjusted OR (OR = 1.39, CI = 1.07, 1.81) and insignificant in adjusted OR (OR = 0.67, CI = 0.37, 1.20). The effect of sulfonylurea consumption on CRC was significant in both unadjusted (OR = 2.39, CI = 1.40, 4.09) and adjusted ORs (OR = 2.35, CI = 1.12, 4.91). All analyses related to the relationship between T2D and tumor clinicopathological characteristics were insignificant. CONCLUSION: This study found an insignificant association between type 2 diabetes and the chance of CRC development in an adjusted state. Sulfonylurea consumption was also associated with a higher chance of CRC development among patients with T2D. These findings have implications for clinical practice and public health strategies in CRC prevention for patients with T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Student Research Committee, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran. Agah.sh@Iums.ac.ir.
- Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Student Research Committee, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Zitieren
APA
Rezazadeh, M., Agah, S., Kamyabi, A., Akbari, A., Ghamkhari Pisheh, R., Eshraghi, A., Babakhani, A., Ahmadi, A., Paseban, M., Heidari, P., Shirinkam, I., & Mehrdad, A. (2024). Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03477-4
Vancouver
Rezazadeh M, Agah S, Kamyabi A, Akbari A, Ghamkhari Pisheh R, Eshraghi A, et al. Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03477-4
BibTeX
@article{Rezazadeh2024,
author = {Rezazadeh, Mohammad and Agah, Shahram and Kamyabi, Amirreza and Akbari, Abolfazl and Ghamkhari Pisheh, Ramtin and Eshraghi, Amirhossein and Babakhani, Alireza and Ahmadi, Alireza and Paseban, Melika and Heidari, Parnian and Shirinkam, Ilia and Mehrdad, Amirabbas},
title = {Effect of diabetes mellitus type 2 and sulfonylurea on colorectal cancer development: a case-control study},
journal = {BMC Gastroenterology},
year = {2024},
doi = {10.1186/s12876-024-03477-4}
}
EUVIMED